Top compounds associated with response to APPL2


Feature Type Standardized
Nominal ANOVA
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.1
mRNA MLN4924 GDSC1000 pan-cancer AAC -0.066 0.1
mRNA dacarbazine CTRPv2 pan-cancer AAC -0.053 0.1
mRNA Bosutinib FIMM pan-cancer AAC 0.68 0.1
mRNA UNC0321 CTRPv2 pan-cancer AAC 0.062 0.1
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.05 0.1
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.1
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.054 0.1
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC -0.061 0.1
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.1
Download CSV